glutathione dosage FAQ

Glutathione supplementation does not require daily dosing to be effective. Intracellular glutathione pools turn over slowly, and intermittent dosing can still provide oxidative stress benefits. A 2021 trial using liposomal GSH 500mg three times weekly (Monday, Wednesday, Friday) showed sustained increases in erythrocyte glutathione and reductions in lipid peroxidation markers over 12 weeks. If you miss a dose, resume your normal schedule the next day. Do not double-dose to compensate. Glutathione synthesis is feedback-regulated, so flooding the system with excess glutathione in a single dose will not proportionally increase tissue levels.

Switch to NAC (N-acetylcysteine) instead. It's widely available, inexpensive, and clinically proven to elevate hepatic glutathione when oral GSH bioavailability is insufficient. A 600mg NAC dose twice daily (1200mg total) provides more hepatic glutathione support than 1000mg of non-liposomal oral glutathione due to superior cysteine absorption. Pairing NAC with glycine (3–5g daily) and selenium (200mcg daily) further supports the GCL synthesis pathway.

Glutathione supplementation without adequate selenium is functionally ineffective because glutathione peroxidase (the enzyme that uses GSH to neutralise peroxides) is selenium-dependent. A 2021 intervention trial found that 1,000mg daily liposomal GSH produced no oxidative biomarker improvements in selenium-deficient participants (serum selenium <70 mcg/L). Test serum selenium levels or supplement 200mcg daily selenomethionine as a baseline. Similarly, cysteine availability limits glutathione synthesis. NAC (600–1,200mg daily) provides stable cysteine precursors that deacetylate intracellularly. Stack both cofactors with glutathione for maximum detoxification efficacy.

Lack of visible lightening after 8 weeks on 500–1,000mg oral reduced L-glutathione suggests one of four issues: (1) you're taking oxidised glutathione (GSSG) instead of reduced form, (2) you're not co-administering vitamin C, (3) your baseline melanin density is high enough that 15% reduction isn't perceptible yet, or (4) genetic variation in glutathione metabolism affects your response. Verify your supplement label specifies 'reduced L-glutathione' and add 500–1,000mg vitamin C if you haven't already. If compliance and co-factors are correct but results remain absent, consider switching to IV glutathione at 1,200mg weekly for 8 weeks. IV bypasses variability in oral absorption entirely and demonstrates response within 4–6 weeks in most cases.

Switch to liposomal or acetylated glutathione immediately. Standard oral reduced GSH shows less than 10% bioavailability in published studies. Gastric acid and intestinal proteases break the tripeptide into constituent amino acids before it reaches systemic circulation. A 500mg capsule of unprotected GSH delivers approximately 50mg or less to your bloodstream, and even that fraction faces rapid oxidation before reaching intracellular compartments. The European Journal of Nutrition study demonstrated zero significant increase in lymphocyte GSH concentrations with standard oral forms, while liposomal preparations increased levels by 41%. If you've been taking standard capsules for weeks without noticing changes in recovery, energy, or oxidative stress markers, bioavailability failure is the likely explanation.

Increase to 1000mg twice daily during the acute phase (first 48–72 hours), then return to 500mg twice daily for maintenance. Immune cells consume glutathione rapidly during infection. Viral replication in host cells generates oxidative stress that depletes intracellular GSH by 40–60% within hours. The higher dose compensates for accelerated turnover without exceeding detoxification capacity. Pair with vitamin C (1000mg) and zinc (30mg). Both support glutathione recycling and immune cell function through complementary mechanisms.

Missing 1–3 days of oral glutathione doesn't reverse melanin reduction already achieved, but it slows further progress because plasma GSH levels drop back to baseline within 24–48 hours of stopping supplementation. Melanocytes don't 'rebound' with increased melanin synthesis after brief interruptions. The effect is gradual tone stabilisation rather than rapid darkening. Resume your standard 500–1,000mg dose as soon as you remember; don't double-dose to compensate. Consistency matters more than perfection. Patients who maintain 80% adherence over 12 weeks still achieve meaningful melanin reduction, just at a slightly slower rate than 100% adherence.

Combining glutathione with NAC is synergistic, not redundant. NAC provides cysteine, the rate-limiting amino acid for endogenous glutathione synthesis via the gamma-glutamylcysteine synthetase pathway. Supplemental GSH raises plasma and tissue levels directly, while NAC supports intracellular production. A 2023 study in Antioxidants using 600mg NAC plus 500mg liposomal GSH daily demonstrated 52% higher intracellular GSH in lymphocytes compared to GSH alone. The combination addresses both immediate antioxidant need and sustained synthesis capacity. We've observed this pairing in research protocols targeting chronic oxidative conditions where both rapid intervention and long-term synthesis support are required.

Reduce to 250–500mg and split into two daily doses, or switch from oral to sublingual administration. Gastrointestinal side effects (bloating, mild nausea, loose stools) occur in approximately 15–20% of users at doses above 1,000mg, particularly with liposomal forms that contain phospholipids. The mechanism involves osmotic water retention in the intestinal lumen and altered gut motility from high phospholipid loads. Splitting a 1,000mg dose into 500mg twice daily (morning and early afternoon) distributes the osmotic load while maintaining plasma GSH elevation throughout the day. Sublingual reduced glutathione bypasses the GI tract entirely, eliminating digestive side effects, though total absorbed dose will be lower due to limited mucosal surface area.

Dose 500mg 30–60 minutes pre-workout and 500mg within two hours post-workout. Intense exercise (>75% VO2 max for >90 minutes) temporarily suppresses immune function through a mechanism called the 'open window'. Elevated cortisol, reduced salivary IgA, and lymphocyte redistribution away from mucosal surfaces. Glutathione doesn't prevent the window but shortens it. Research in the Journal of the International Society of Sports Nutrition found that athletes supplementing 1000mg daily glutathione had 30% fewer upper respiratory infections during heavy training blocks compared to placebo.

Yes, but adjust expectations. GSTM1-null individuals (roughly 50% prevalence) have reduced capacity to conjugate certain toxins but retain GSTP1 and GSTT1 function. Focus on supporting those pathways with adequate glutathione (500–1000mg daily) plus enhanced antioxidant support (vitamin C 1000mg, alpha-lipoic acid 300–600mg) to compensate for reduced GST efficiency. The detox timeline will be longer. Expect 24–32 weeks rather than 12–16. And consider adding mild chelators like modified citrus pectin to support excretion through mechanisms independent of GST.

Oral high-bioavailability glutathione (liposomal or acetylated) at 1,000–1,500mg daily can support chelation protocols, but intravenous glutathione provides faster and more reliable tissue saturation. A 2022 study on lead chelation found that IV GSH (1,000mg twice weekly) alongside DMSA reduced blood lead levels 41% versus 28% with DMSA alone. If IV administration isn't accessible, combine oral glutathione with NAC (1,200mg daily) and selenium (200mcg daily) to maximise endogenous synthesis. Heavy metal detoxification is a medical intervention. Work with a practitioner experienced in chelation protocols rather than self-administering high-dose glutathione without monitoring.

Acetaminophen depletes hepatic glutathione through NAPQI (N-acetyl-p-benzoquinone imine) formation during Phase I metabolism. This is the mechanism behind acetaminophen hepatotoxicity at overdose levels. Chronic acetaminophen use (>2g daily) increases glutathione demand, making NAC supplementation (600–1200mg daily) the most effective protective strategy rather than dose-escalating direct glutathione. NAC provides the cysteine substrate needed to replenish glutathione reserves faster than replacement therapy alone.

Reduce dose to 250–500mg and split into smaller increments taken with food. GI distress typically indicates sulfur overload exceeding your transsulfuration capacity. Adding molybdenum (150–300mcg daily) supports sulfite oxidase, the enzyme that processes excess sulfur metabolites, which can reduce symptoms within 3–5 days. If symptoms persist below 500mg daily, switch to IV pulse dosing (bypasses GI tract entirely) or address underlying gut dysbiosis. Hydrogen sulfide-producing bacteria can amplify sulfur intolerance.

Switch to liposomal or acetylated glutathione at 500–1,000mg daily before increasing your dose further. Standard oral GSH at 1,000–2,000mg daily produces minimal plasma elevation due to enzymatic breakdown in the GI tract. You're paying for glutathione that never reaches circulation. A 2023 pharmacokinetics study found that 500mg liposomal GSH produced higher plasma glutathione levels than 2,000mg oral reduced GSH taken at the same time. If cost is a constraint, acetylated glutathione offers better bioavailability than standard oral forms at a lower price point than liposomal.

Recalculate your concentration using the actual volume added and adjust your injection volume accordingly. The peptide is not ruined, only diluted. If you intended to add 2mL to a 200mg vial but added 4mL instead, your concentration is now 50mg/mL rather than 100mg/mL. To achieve a 100mg dose, draw 2mL instead of 1mL. The limitation is injection volume: if your target dose now requires more than 1.5mL per injection, you must either split the dose across two injection sites, reduce the dose, or discard the vial and reconstitute a new one correctly. There is no method to remove bacteriostatic water once added. Dilution is irreversible. Label the vial with the correct recalculated concentration to prevent confusion on subsequent draws.

Recalculate injection volume using the same concentration formula. The concentration in the vial does not change once reconstituted, only the volume you draw per injection changes. If you reconstituted a 600mg vial with 3mL bacteriostatic water (yielding 200mg/mL) and have been using 1mL per injection for 200mg doses, but now want to reduce to 100mg doses, simply draw 0.5mL per injection instead. The remaining solution stays at 200mg/mL concentration. Your vial will now last twice as long. Conversely, if you want to increase from 100mg to 150mg, draw 0.75mL per injection. The only constraint is total vial content: a 600mg vial can deliver six 100mg doses, four 150mg doses, or three 200mg doses. But not a combination that exceeds 600mg total.

Use an insulin syringe marked in units, where 100 units = 1mL on a U-100 syringe. This is the standard in research and clinical settings. If your calculation requires 0.5mL, draw to the 50-unit mark. If it requires 0.25mL, draw to 25 units. If you are using a syringe marked only in cc (cubic centimetres), 1cc = 1mL. The terms are interchangeable. Avoid tuberculin syringes or non-insulin syringes for peptide work unless you are experienced in volume conversion, as inconsistent marking systems introduce calculation errors. Real Peptides recommends using 0.3mL to 1mL insulin syringes with 29–31 gauge needles for all subcutaneous peptide injections. These provide the precision required for accurate dosing and minimize injection site trauma.

Calculate reconstitution and dosing for each peptide independently. Never mix different peptides in the same vial unless you are following a pre-formulated stack with validated stability data. Glutathione reconstituted in one vial at 100mg/mL and BPC-157 reconstituted in another vial at 250mcg/mL require separate calculations and separate injections, even if administered at the same time. If you are running a combination protocol, calculate total injection volume across all peptides to ensure you stay within the 1.5mL per site threshold. For example, 0.5mL glutathione + 0.4mL BPC-157 + 0.3mL Thymosin Alpha-1 = 1.2mL total, which is acceptable for a single subcutaneous site. Exceeding this requires splitting across multiple sites or adjusting reconstitution volumes to create higher concentrations and smaller per-peptide injection volumes.

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.